1. Are Mental Health Services Losing Out in the US Under Managed Care?

   • Dale L. Johnson

   Current Opinion 03 December 2012 Pages: 597 - 601

2. Thrombolysis, Stroke Units and Other Strategies for Reducing Acute Stroke Costs

   • Theodore H. Wein
   • Susan L. Hickenbottom
   • Andrei V. Alexandrov

   Leading Article 03 December 2012 Pages: 603 - 611

3. A Review of Quality of Life in Alzheimer’s Disease

   • Sam S. Salek
   • Melvyn D. Walker
   • Antony J. Bayer

   Review Article 03 December 2012 Pages: 613 - 627

4. Insomnia, Health-Related Quality of Life and Healthcare Resource Consumption

   • Hind T. Hatoum
   • Sheldon X. Kong
   • Wallace B. Mendelson

   Original Research Article 03 December 2012 Pages: 629 - 637

5. The Use and Cost of HIV Service Provision in England in 1996

   • Eduard J. Beck
   • Keith Tolley
   • Ian Williams

   Original Research Article 03 December 2012 Pages: 639 - 652

6. Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction

   • Peter K. Schädlich
   • Eduard Huppertz
   • Josef Georg Brecht

   Original Research Article 03 December 2012 Pages: 653 - 669

7. Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma

   • Maureen P. M. H. Rutten-van Mölken
   • Eddy K. A. van Doorslaer
   • M. Denise Till

   Original Research Article 03 December 2012 Pages: 671 - 684

8. Fosphenytoin

   • Stephen M. Holliday
   • Paul Benfield
   • Greg L. Plosker

   Adis Formulary Perspective 03 December 2012 Pages: 685 - 690

9. Cyclosporin Microemulsion (Neoral®)†

   • Allan J. Coukell
   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 03 December 2012 Pages: 691 - 708

10. A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe

    • Linda D. MacKeigan

    Correspondence 03 December 2012 Pages: 709 - 709

11. The authors reply

    • Sheila Hood
    • Lieven Annemans
    • Maureen Rutten-van Mölken

    Correspondence 03 December 2012 Pages: 710 - 711

12. Common Errors and Controversies in Pharmacoeconomic Analyses

    • Javier Soto

    Correspondence 03 December 2012 Pages: 711 - 712

13. Correspondence

    Correspondence 03 December 2012 Pages: 713 - 714